Postnatal steroids as lung protective and anti-inflammatory in preterm lambs exposed to antenatal inflammation

Pediatr Res. 2024 Mar;95(4):931-940. doi: 10.1038/s41390-023-02911-9. Epub 2023 Dec 8.

Abstract

Background: Lung inflammation and impaired alveolarization precede bronchopulmonary dysplasia (BPD). Glucocorticoids are anti-inflammatory and reduce ventilator requirements in preterm infants. However, high-dose glucocorticoids inhibit alveolarization. The effect of glucocorticoids on lung function and structure in preterm newborns exposed to antenatal inflammation is unknown. We hypothesise that postnatal low-dose dexamethasone reduces ventilator requirements, prevents inflammation and BPD-like lung pathology, following antenatal inflammation.

Methods: Pregnant ewes received intra-amniotic LPS (E.coli, 4 mg/mL) or saline at 126 days gestation; preterm lambs were delivered 48 h later. Lambs were randomised to receive either tapered intravenous dexamethasone (LPS/Dex, n = 9) or saline (LPS/Sal, n = 10; Sal/Sal, n = 9) commencing <3 h after birth. Respiratory support was gradually de-escalated, using a standardised protocol aimed at weaning from ventilation towards unassisted respiration. Tissues were collected at day 7.

Results: Lung morphology and mRNA levels for inflammatory mediators were measured. Respiratory support requirements were not different between groups. Histological analyses revealed higher tissue content and unchanged alveolarization in LPS/Sal compared to other groups. LPS/Dex lambs exhibited decreased markers of pulmonary inflammation compared to LPS/Sal.

Conclusion: Tapered low-dose dexamethasone reduces the impact of antenatal LPS on ventilation requirements throughout the first week of life and reduces inflammation and pathological thickening of the preterm lung IMPACT: We are the first to investigate the combination of antenatal inflammation and postnatal dexamethasone therapy in a pragmatic study design, akin to contemporary neonatal care. We show that antenatal inflammation with postnatal dexamethasone therapy does not reduce ventilator requirements, but has beneficial maturational impacts on the lungs of preterm lambs at 7 days of life. Appropriate tapered postnatal dexamethasone dosing should be explored for extuabtion of oxygen-dependant neonates.

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / pharmacology
  • Bronchopulmonary Dysplasia* / prevention & control
  • Dexamethasone / pharmacology
  • Female
  • Glucocorticoids / pharmacology
  • Humans
  • Infant
  • Infant, Newborn
  • Infant, Premature
  • Inflammation
  • Lipopolysaccharides*
  • Lung
  • Pregnancy
  • Sheep
  • Sheep, Domestic
  • Steroids

Substances

  • Lipopolysaccharides
  • Anti-Inflammatory Agents
  • Glucocorticoids
  • Steroids
  • Dexamethasone